SCHEMBL25307340

SCHEMBL25307340

CN(C)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1.[NaH]

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.96
TSHR P16473 3/20 0.96
LMNA P02545 2/20 0.96
GAA P10253 2/20 0.96
MAPK1 P28482 3/20 0.61
MAPT P10636 3/20 0.61
KDM4E B2RXH2 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
HPGD P15428 1/20 0.61
HTT P42858 1/20 0.61
CYP1A2 P05177 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CYP3A4 P08684 2/20 0.52
BLM P54132 2/20 0.52
ATM Q13315 2/20 0.52
HIF1A Q16665 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
CYP2C9 P11712 2/20 0.52
ALOX15 P16050 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38719 0.98 ALDH1A1 (1.00) ALDH1A1TSHRLMNAGAAMAPK1
SCHEMBL30343310 0.96 ALDH1A1 (0.96) ALDH1A1TSHRLMNAGAAMAPK1
Hydrochloric Acid SCHEMBL1592741 0.96 ALDH1A1 (0.96) ALDH1A1TSHRLMNAGAAMAPK1
SCHEMBL25262628 0.96 ALDH1A1 (0.96) ALDH1A1TSHRLMNAGAAMAPK1
SCHEMBL25308455 0.96 ALDH1A1 (0.96) ALDH1A1TSHRLMNAGAAMAPK1
SCHEMBL11636500 0.92 ALDH1A1 (0.89) ALDH1A1TSHRLMNAGAAMAPK1
Boric Acid SCHEMBL9665661 0.92 ALDH1A1 (0.89) ALDH1A1TSHRLMNAGAAMAPK1
SCHEMBL9345626 0.91 ALDH1A1 (0.86) ALDH1A1TSHRLMNAGAAMAPK1
Catechol SCHEMBL9664944 0.88 ALDH1A1 (0.80) ALDH1A1TSHRLMNAGAAMAPK1
SCHEMBL8940780 0.88 ALDH1A1 (0.80) ALDH1A1TSHRLMNAGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545782-B2 Thermally curable compositions, thermally cured compositions, and articles prepared therefrom 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-10 US claimed
US-20230279216-A1 THERMALLY CURABLE COMPOSITIONS, THERMALLY CURED COMPOSITIONS, AND ARTICLES PREPARED THEREFROM 3M INNOVATIVE PROPERTIES COMPANY 2023-09-07 US claimed
EP-4204474-A1 THERMALLY CURABLE COMPOSITIONS, THERMALLY CURED COMPOSITIONS, AND ARTICLES PREPARED THEREFROM 3M Innovative Properties Company (US) 2023-07-05 EP claimed
US-12545782-B2 Thermally curable compositions, thermally cured compositions, and articles prepared therefrom 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-10 US disclosed
US-20230279216-A1 THERMALLY CURABLE COMPOSITIONS, THERMALLY CURED COMPOSITIONS, AND ARTICLES PREPARED THEREFROM 3M INNOVATIVE PROPERTIES COMPANY 2023-09-07 US disclosed
EP-4204474-A1 THERMALLY CURABLE COMPOSITIONS, THERMALLY CURED COMPOSITIONS, AND ARTICLES PREPARED THEREFROM 3M Innovative Properties Company (US) 2023-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545782-B2 Thermally curable compositions, thermally cured compositions, and articles prepared therefrom TERT, ARCN1, MRPL12 ALDH1A1 1766/4885TSHR 3737/4885LMNA 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.